NYSE:EW

Edwards Lifesciences Stock News

etoro logo Buy EW
*Your capital is at risk
$86.00
-1.66 (-1.89%)
At Close: Jun 03, 2026

Unreliable Contrarianism

03:23pm, Tuesday, 20'th Dec 2022
It appears to us at Smead Capital Management that investors are behaving in a way that will damage their capital and cause them to suffer stock market failure. In 2022, as the favorite tech stocks of
Cramer said that healthcare stocks have stayed relatively steady this year because they tend to be recession-resistant stocks.
IRVINE, Calif. , Dec. 8, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) will discuss the company's strategy for longer-term growth, provide an update on its technology pipeline and s
Amid rising concerns about the state of the global economy, rising inflation, central bank interest rate hikes and increased Covid-19 restrictions in China, marked indexes were mixed on Wednesday morn
The healthcare sector has gained momentum following the COVID-19 pandemic. Several companies gained early regulatory approval for developing COVID-19 drugs and distributing vaccines.
Heart disease equipment maker Edwards Life Sciences (NYSE: EW) stock has fallen (-46%) on the year after a disastrous reaction to its Q3 2022 earnings report.
As investors get ready for Halloween, five broadly held guru stocks that tumbled more than 10% during October are Meta Platforms Inc. ( META , Financial), Amazon.com Inc. ( AMZN , Financial), Alibaba
Although the concept of stocks to buy at the ‘midterm elections' bottom seems farfetched considering the broader volatility this year, the calendar might provide a change of heart. According to The

Edwards Lifesciences: Opening My Heart

06:16am, Sunday, 30'th Oct 2022
Edwards Lifesciences has seen shares cut nearly in half from the highs of last year. This is mostly in response to higher interest rates and an overreaction seen towards the upside last year.
Edwards Lifesciences (EW) continues to register strong momentum in TMTT on a portfolio of differentiated therapies, positive pivotal trial results and favorable real-world clinical outcomes.
Did investors overreact to the company's miss?
Edwards Lifesciences says quarterly sales for its transcatheter aortic valve replacement rose 1% but were impacted by, among other things, 'persistent U.S. hospital staffing shortages.'
Edwards Lifesciences Corp (NYSE:EW ) Q3 2022 Earnings Conference Call October 27, 2022 5:00 PM ET Company Participants Mark Wilterding - VP, IR Michael Mussallem - Chairman & CEO Scott Ullem - Corpora
Edwards Lifesciences slashed its 2022 profit outlook on Thursday, noting hospital and dollar challenges. But EW stock remained muted.
IRVINE, Calif. , Oct. 20, 2022 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended September 30, 2022 after the market closes on Thursday, Oc
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE